Scientists have identified the HMGA2 gene, a common variant of which directly influences height. The study found that variations in this gene make some people taller than others, with 25% of white Europeans carrying two 'tall' versions and approximately 1cm difference in height.
A novel intracellular traffic coordinator, SNX27, regulates potassium channel activity in brain cells by pulling them away from their job, reducing excitability. This discovery could lead to new treatments for drug addictions.
A new study reveals that mast cells not only cause allergic reactions but also help reduce skin damage and inflammation from sun exposure or poison oak. The discovery opens up new possibilities for treating allergies and other conditions.
Scientists discover new viruses that target specific types of bacteria, offering an alternative to conventional antibiotic therapy. The approach has potential to combat antibiotic resistance and superbug infections such as MRSA.
The SCAI has announced that its leaders are available for comment on numerous studies, trials, and data releases at the upcoming European Society for Cardiology Congress. These studies focus on interventional cardiology, percutaneous intervention, angioplasty, and stents.
A genome-wide association study has identified a genetic variant associated with human height, revealing the first consistent link between genes and height. The HMGA2 gene variation adds about half centimeter in height for one copy and almost full centimeter for two copies.
Researchers at Princeton University have invented a new process called fracture-induced structuring that enables the self-formation of periodic lines, or gratings, separated by as few as 60 nanometers. This technique uses a thin polymer film and is simpler and faster than traditional methods, making it economically feasible for large-s...
Year-round consumption of fresh leafy greens like lettuce poses challenges due to increased risk of E. coli contamination from field sources. New methods, including harvesting mowers and triple washing, are being used to address this issue.
The ADVANCE trial found that a fixed combination of perindopril and indapamide reduced the risk of death from cardiovascular disease by 18% and major macrovascular or microvascular events by 9%. The results suggest that this treatment could be considered routinely for patients with type 2 diabetes to prevent complications.